Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of anesthetic method on cochlear microphonic potential during cochlear implantation
ChiCTR2600121958Phase 4Not yet recruiting
- Sponsor
- Shanghai Ninth People's Hospital
- Start
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of propofol and sevoflurane in sensorineural hearing loss (SNHL) and Hypoacusis (2 arms), sponsored by Shanghai Ninth People's Hospital. Primary endpoint: Median effective dose (ED50) for recordable CM response. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
propofolsevoflurane
03
Conditions
sensorineural hearing loss (SNHL)Hypoacusis
Beyond the preview
Go deeper on ChiCTR2600121958.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600121958.